M1 Kliniken Future Growth
Future criteria checks 3/6
M1 Kliniken is forecast to grow earnings and revenue by 17.5% and 23% per annum respectively. EPS is expected to grow by 15.8% per annum. Return on equity is forecast to be 18.7% in 3 years.
Key information
17.5%
Earnings growth rate
15.8%
EPS growth rate
| Healthcare earnings growth | 20.6% |
| Revenue growth rate | 23.0% |
| Future return on equity | 18.7% |
| Analyst coverage | Low |
| Last updated | 06 Sep 2024 |
Recent future growth updates
Recent updates
Why We're Not Concerned Yet About M1 Kliniken AG's (ETR:M12) 27% Share Price Plunge
Aug 03
Additional Considerations Required While Assessing M1 Kliniken's (ETR:M12) Strong Earnings
Jun 06M1 Kliniken AG (ETR:M12) Looks Just Right With A 53% Price Jump
May 29M1 Kliniken (ETR:M12) Might Be Having Difficulty Using Its Capital Effectively
May 03At €14.40, Is It Time To Put M1 Kliniken AG (ETR:M12) On Your Watch List?
Mar 07Why Investors Shouldn't Be Surprised By M1 Kliniken AG's (ETR:M12) 25% Share Price Surge
Feb 18Is M1 Kliniken AG (ETR:M12) Trading At A 46% Discount?
Feb 17An Intrinsic Calculation For M1 Kliniken AG (ETR:M12) Suggests It's 27% Undervalued
Sep 01Should You Think About Buying M1 Kliniken AG (ETR:M12) Now?
Jun 01The Returns On Capital At M1 Kliniken (ETR:M12) Don't Inspire Confidence
Mar 25Investors Could Be Concerned With M1 Kliniken's (ETR:M12) Returns On Capital
Dec 17Is Now The Time To Look At Buying M1 Kliniken AG (ETR:M12)?
Nov 02Time To Worry? Analysts Are Downgrading Their M1 Kliniken AG (ETR:M12) Outlook
May 26Analysts Have Lowered Expectations For M1 Kliniken AG (ETR:M12) After Its Latest Results
May 25Here's What's Concerning About M1 Kliniken's (ETR:M12) Returns On Capital
Dec 06There Are Reasons To Feel Uneasy About M1 Kliniken's (ETR:M12) Returns On Capital
May 22Here's What M1 Kliniken AG's (ETR:M12) Shareholder Ownership Structure Looks Like
Mar 19We're Watching These Trends At M1 Kliniken (ETR:M12)
Feb 21M1 Kliniken (ETR:M12) Has Gifted Shareholders With A Fantastic 106% Total Return On Their Investment
Feb 03
Are Dividend Investors Getting More Than They Bargained For With M1 Kliniken AG's (ETR:M12) Dividend?
Jan 16M1 Kliniken AG's (ETR:M12) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?
Dec 29Here's Why We Don't Think M1 Kliniken's (ETR:M12) Statutory Earnings Reflect Its Underlying Earnings Potential
Dec 14When Should You Buy M1 Kliniken AG (ETR:M12)?
Nov 28Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 405 | 24 | 25 | 29 | 2 |
| 12/31/2025 | 372 | 18 | 20 | 24 | 2 |
| 12/31/2024 | 341 | 14 | 17 | 22 | 2 |
| 6/30/2024 | N/A | 17 | 20 | 20 | N/A |
| 3/31/2024 | N/A | 14 | 14 | 14 | N/A |
| 12/31/2023 | 316 | 10 | 7 | 8 | N/A |
| 9/30/2023 | 307 | N/A | 9 | 10 | N/A |
| 6/30/2023 | 297 | N/A | -1 | N/A | N/A |
| 3/31/2023 | 291 | N/A | -2 | N/A | N/A |
| 12/31/2022 | 285 | 4 | 19 | 21 | N/A |
| 9/30/2022 | 287 | 6 | 20 | 22 | N/A |
| 6/30/2022 | 288 | 7 | 21 | 22 | N/A |
| 3/31/2022 | 302 | 8 | 18 | 19 | N/A |
| 12/31/2021 | 315 | 9 | 14 | 16 | N/A |
| 9/30/2021 | 304 | 9 | N/A | N/A | N/A |
| 6/30/2021 | 293 | 10 | 14 | 15 | N/A |
| 3/31/2021 | 226 | 8 | 11 | 12 | N/A |
| 12/31/2020 | 160 | 7 | 8 | 10 | N/A |
| 9/30/2020 | 118 | 7 | N/A | N/A | N/A |
| 6/30/2020 | 76 | 6 | -9 | -8 | N/A |
| 3/31/2020 | 77 | 8 | -8 | -7 | N/A |
| 12/31/2019 | 77 | 10 | -7 | -5 | N/A |
| 9/30/2019 | 73 | 8 | -4 | -2 | N/A |
| 6/30/2019 | 69 | 7 | 0 | 1 | N/A |
| 3/31/2019 | 67 | 7 | 0 | 2 | N/A |
| 12/31/2018 | 65 | 7 | 1 | 3 | N/A |
| 9/30/2018 | 60 | 6 | -1 | 1 | N/A |
| 6/30/2018 | 54 | 5 | -2 | 0 | N/A |
| 3/31/2018 | 51 | 6 | N/A | 1 | N/A |
| 12/31/2017 | 47 | 6 | N/A | 2 | N/A |
| 9/30/2017 | 43 | 6 | N/A | 5 | N/A |
| 6/30/2017 | 40 | 6 | N/A | 8 | N/A |
| 3/31/2017 | 38 | 5 | N/A | 8 | N/A |
| 12/31/2016 | 36 | 5 | N/A | 8 | N/A |
| 9/30/2016 | 40 | 7 | N/A | 7 | N/A |
| 6/30/2016 | 43 | 10 | N/A | 5 | N/A |
| 3/31/2016 | 39 | 8 | N/A | 3 | N/A |
| 12/31/2015 | 35 | 7 | N/A | 0 | N/A |
| 12/31/2014 | 23 | 5 | N/A | 1 | N/A |
| 12/31/2013 | 6 | 0 | N/A | -5 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: M12's forecast earnings growth (17.5% per year) is above the savings rate (0.8%).
Earnings vs Market: M12's earnings (17.5% per year) are forecast to grow slower than the German market (20% per year).
High Growth Earnings: M12's earnings are forecast to grow, but not significantly.
Revenue vs Market: M12's revenue (23% per year) is forecast to grow faster than the German market (5.4% per year).
High Growth Revenue: M12's revenue (23% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: M12's Return on Equity is forecast to be low in 3 years time (18.7%).